Kamizato Kota

写真a

Title

Instructor

Researcher Number(JSPS Kakenhi)

10554454

Current Affiliation Organization 【 display / non-display

  • Duty   University of the Ryukyus   Faculty of Medicine   University Hospital   Instructor  

External Career 【 display / non-display

  • 2011.04
     
     

    University of the Ryukyus, Faculty of Medicine, University Hospital, Instructor  

Affiliated academic organizations 【 display / non-display

  •  
     
     
     

    JAPANESE SOCIETY OF ANESTHESIOLOGISTS 

  •  
     
     
     

    THE JAPANESE SOCIETY OF INTENSIVE CARE MEDICINE 

  •  
     
     
     

    THE JAPAN SOCIETY FOR CLINICAL ANESTHESIA 

  •  
     
     
     

    JAPANESE SOCIETY FOR APHERESIS 

Published Papers 【 display / non-display

  • Two cases of airway obstruction by blood clot after percutaneous airway

    Nishi Hiroyuki, Kamisato Kota, Teruya Koji, Fuchigami Tatsuya, Kakinohana Manabu

    Journal of the Japanese Society of Intensive Care Medicine ( The Japanese Society of Intensive Care Medicine )  27 ( 2 ) 109 - 110   2020.03 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats.

    Marsala M, Kamizato K, Tadokoro T, Navarro M, Juhas S, Juhasova J, Marsala S, Studenovska H, Proks V, Hazel T, Johe K, Kakinohana M, Driscoll S, Glenn T, Pfaff S, Ciacci J

    Stem cells translational medicine     2019.12 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation.

    Kamizato K, Marsala S, Navarro M, Kakinohana M, Platoshyn O, Yoshizumi T, Lukacova N, Wancewicz E, Powers B, Mazur C, Marsala M

    Experimental neurology ( Experimental Neurology )  305   66 - 75   2018.07 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.

    Strnadel J, Carromeu C, Bardy C, Navarro M, Platoshyn O, Glud AN, Marsala S, Kafka J, Miyanohara A, Kato T Jr, Tadokoro T, Hefferan MP, Kamizato K, Yoshizumi T, Juhas S, Juhasova J, Ho CS, Kheradmand T, Chen P, Bohaciakova D, Hruska-Plochan M, Todd AJ, Driscoll SP, Glenn TD, Pfaff SL, Klima J, Ciacci J, Curtis E, Gage FH, Bui J, Yamada K, Muotri AR, Marsala M

    Science translational medicine   10 ( 440 )   2018.05 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Outcome of non-surgical septic shock patients treated with polymyxin B hemoperfusion:single center retrospective study

    Japanese Journal of Reanimatology ( The Japanese Society of Reanimatology )  37 ( 1 ) 8 - 11   2018 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

     View Summary

    <p>Objectives:To research the efficacy of polymyxin B direct hemoperfusion (PMX-DHP) on non-surgical patients with septic shock.Methods:This was a single center, retrospective study, from January 2012 to January 2016. We extracted data for non-surgical septic shock patients treated with PMX-DHP. The primary outcome was mortality on day 28, and secondary outcomes were reductions of the catecholamine index (CAI), lactate levels, and SOFA score.Results:Overall, in 24 patients, the APACHE II score and SOFA score were 26 (IQR 21-31.25) and 14.5 (IQR 11-17), respectively. The 28-day mortality was 54%. The CAI tended to decrease after PMX-DHP but did not show any significant differences. Patients with decreased CAI presented with a lower 28-day mortality. Any patient who received with PMX-DHP, which started on one day or later after the first administration of antibiotics for septic shock, did not survive. The 28-day mortality was high in patients with low left ventricular ejection fraction.Conclusions:In this retrospective study, PMX-DHP did not show any benefits of assured decreased mortality for non-surgical patients in septic shock. This might be an important finding when PMX-DHP is initiated in patients in septic shock.</p>

display all >>

Other Papers 【 display / non-display

  • 【ICU治療指針 I】中枢神経疾患と管理 内頸静脈球部酸素飽和度測定

    神里 興太

    救急・集中治療 ( (株)総合医学社 )  31 ( 2 ) 335 - 337   2019.07

     

  • 【ICU治療指針 I】中枢神経疾患と管理 脊髄硬膜下血腫・硬膜外血腫

    神里 興太

    救急・集中治療 ( (株)総合医学社 )  31 ( 2 ) 290 - 292   2019.07

     

  • 【ICU治療指針 I】中枢神経疾患と管理 脊髄梗塞

    神里 興太

    救急・集中治療 ( (株)総合医学社 )  31 ( 2 ) 287 - 289   2019.07

     

  • 【周術期の呼吸管理】心臓・大血管手術の周術期呼吸管理

    神里 興太, 垣花 学

    麻酔 ( 克誠堂出版(株) )  67 ( 5 ) 470 - 476   2018.05  [Refereed]

     

  • 【まれだが怖い 手術・麻酔合併症】覚醒後の頻脈,低酸素,そして頸部の腫脹 まず何をするべきか? 診断の決め手は?

    神里 興太, 垣花 学

    LiSA ( (株)メディカル・サイエンス・インターナショナル )  23 ( 8 ) 716 - 719   2016.08

     

Grant-in-Aid for Scientific Research 【 display / non-display

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -   

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -   

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -  2022.03 

    Direct: 3,400,000 (YEN)  Overheads: 4,420,000 (YEN)  Total: 1,020,000 (YEN)

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -  2022.03 

    Direct: 3,400,000 (YEN)  Overheads: 4,420,000 (YEN)  Total: 1,020,000 (YEN)

  • Grant-in-Aid for Scientific Research(C)

    Project Year: 2019.04  -  2022.03 

    Direct: 3,400,000 (YEN)  Overheads: 4,420,000 (YEN)  Total: 1,020,000 (YEN)

display all >>